After the challenge (hrs) | ||||||||
Patients n = 23 | Before the challenge | 1 | 12 | 24 | 36 | 48 | 56 | 72 |
IL-1β (pg/mL) | ||||||||
DYAR | 4.1 ± 1.1 | 5.0 ± 0.7 | 6.8 ± 1.5* | 7.0 ± 0.6* | 6.9 ± 0.5+ | 5.0 ± 0.2 | 5.1 ± 1.0 | 4.6 ± 0.7 |
PBS | 2.9 ± 0.8 | 4.1 ± 0.8 | 4.2 ± 0.3 | 3.9 ± 0.5 | 3.4 ± 1.0 | 3.0 ± 0.5 | 3.5 ± 0.4 | 3.3 ± 0.2 |
IL-2 (pg/mL) | ||||||||
DYAR | 6.9 ± 0.4 | 5.2 ± 0.1 | 9.6 ± 1.0* | 11.3 ± 0.4* | 11.8 ± 1.7* | 10.4 ± 0.6* | 8.9 ± 0.2* | <3.0 |
PBS | 4.8 ± 0.8 | 5.0 ± 0.9 | 7.1 ± 0.4 | 6.0 ± 0.3 | 4.8 ± 0.6 | 5.3 ± 0.2 | 4.9 ± 0.4 | 4.5 ± 0.4 |
IL-3 (pg/mL) | ||||||||
DYAR | <31.2 | <31.2 | <31.2 | 32.1 ± 0.4 | <31.2 | <31.2 | <31.2 | <31.2 |
PBS | <31.2 | <31.2 | <31.2 | <31.2 | <31.2 | <31.2 | <31.2 | <31.2 |
IL-4 (pg/mL) | ||||||||
DYAR | 3.7 ± 1.0 | 5.0 ± 0.7 | 4.1 ± 0.9 | 2.0 ± 0.3 | <0.6* | <0.6* | <0.6* | 3.3 ± 0.2 |
PBS | 2.9 ± 0.3 | 2.7 ± 1.0 | 3.6 ± 0.8 | 3.4 ± 0.5 | 3.7 ± 0.6 | 2.2 ± 0.3 | 2.6 ± 0.8 | 2.5 ± 1.0 |
IL-5 (pg/mL) | ||||||||
DYAR | 6.9 ± 1.0 | 6.7 ± 0.8 | 6.5 ± 1.3 | 5.0 ± 0.4+ | 5.1 ± 0.7+ | 6.3 ± 1.1 | 7.0 ± 1.0 | 6.4 ± 0.9 |
PBS | 6.5 ± 0.3 | 7.5 ± 1.4 | 7.0 ± 0.7 | 7.0 ± 1.1 | 7.2 ± 0.6 | 7.1 ± 0.4 | 6.3 ± 0.5 | 6.6 ± 1.0 |
IL-6 (pg/mL) | ||||||||
DYAR | 5.0 ± 0.8 | 5.8 ± 0.6 | 8.1 ± 1.1* | 4.6 ± 0.4 | <4.0* | <4.0* | 4.5 ± 0.4 | 5.0 ± 0.5 |
PBS | 5.1 ± 0.5 | 5.1 ± 1.0 | 5.2 ± 0.6 | 5.9 ± 1.3 | 5.0 ± 1.0 | 5.4 ± 0.3 | 4.7 ± 0.5 | 4.5 ± 0.4 |
IL-7 (pg/mL) | ||||||||
DYAR | 4.8 ± 0.5 | 5.7 ± 1.0 | 6.2 ± 0.8 | 6.5 ± 0.4 | 5.9 ± 1.0 | 6.6 ± 0.7 | 6.3 ± 0.4 | 5.8 ± 0.3 |
PBS | 4.4 ± 0.4 | 4.9 ± 0.7 | 5.5 ± 0.9 | 4.8 ± 0.9 | 6.0 ± 1.0 | 6.3 ± 0.8 | 4.6 ± 0.5 | 5.3 ± 0.6 |
IL-8 (pg/mL) | ||||||||
DYAR | 11.2 ± 2.1 | 13.6 ± 1.8 | 15.5 ± 1.0+ | 16.9 ± 1.6* | 17.0 ± 1.4* | 15.8 ± 1.0* | 14.9 ± 1.1+ | 12.8 ± 1.1 |
PBS | 10.5 ± 0.4 | 11.5 ± 0.6 | 12.4 ± 0.5 | 12.6 ± 1.0 | 13.0 ± 1.0 | 12.5 ± 0.7 | 11.5 ± 2.0 | 10.2 ± 1.0 |
IL-10 (pg/mL) | ||||||||
DYAR | 10.9 ± 2.2 | 10.3 ± 0.5 | 11.5 ± 0.8 | 11.2 ± 0.3 | 11.4 ± 1.3 | 11.7 ± 0.5 | 11.0 ± 1.0 | 10.3 ± 0.4 |
PBS | 9.5 ± 0.6 | 10.0 ± 0.3 | 9.8 ± 0.6 | 10.9 ± 1.1 | 11.0 ± 0.7 | 10.8 ± 0.6 | 9.7 ± 0.3 | 10.0 ± 0.7 |
IL-12p40 (pg/mL) | ||||||||
DYAR | 11.7 ± 0.6 | 12.3 ± 1.1 | 12.6 ± 2.0 | 12.6 ± 0.9 | 11.5 ± 1.2 | 11.9 ± 0.7 | 11.6 ± 1.0 | 12.2 ± 0. 6 |
PBS | 11.0 ± 1.4 | 12.0 ± 2.0 | 12.2 ± 1.0 | 11.7 ± 0.7 | 12.1 ± 2.0 | 11.5 ± 0.5 | 11.9 ± 0.8 | 11.4 ± 1.1 |
IL-12p70 (pg/mL) | ||||||||
DYAR | 15.3 ± 1.6 | 15.7 ± 1.1 | 19.4 ± 2.1* | 23.5 ± 2.5* | 24.4 ± 2.6* | 20.1 ± 3.0* | 22.3 ± 1.8* | 16.0 ± 1.0 |
PBS | 15.6 ± 1.4 | 15.0 ± 1.0 | 16.3 ± 1.2 | 16.0 ± 0.6 | 17.6 ± 1.4 | 17.1 ± 0.8 | 16.5 ± 1.0 | 17.0 ± 1.4 |